Antibodies against human papillomavirus type 16 and 18 E6 and E7 proteins in cervicovaginal washings and serum of patients with cervical neoplasia

Viral Immunology

Volumn 14, Issue 4, 2001, Pages 415-424

  Tjiong, M Y ^a   Zumbach, K ^b   Ter Schegget, J ^a,e   Van Der Vange, N ^c   Out, T A ^a,d   Pawlita, M ^b   Struyk, L ^a,e  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b Angew Tumorvirologie Deutsches K   (Germany)

^c NETHERLANDS CANCER INSTITUTE   (Netherlands)

^d CENTRAL LABORATORY   (Netherlands)

^e LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ARTICLE; BLOOD SAMPLING; CARCINOGENESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; PATHOGENICITY; PROTEIN ANALYSIS; UTERINE CERVIX CYTOLOGY; UTERINE CERVIX TUMOR; VACCINATION; WART VIRUS;

ANTIBODIES, VIRAL; CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX MUCUS; DNA-BINDING PROTEINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; ONCOGENE PROTEINS, VIRAL; REPRESSOR PROTEINS; UTERINE CERVICAL NEOPLASMS; VAGINAL DISCHARGE;

DNA VIRUSES; HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPES; PAPILLOMAVIRUS; PAPOVAVIRIDAE;

EID: 0035734565     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/08828240152716655     Document Type: Article

References (30)

1. Aetiology, pathogenesis, and pathology of cervical neoplasia
2. Relation between HPV-16 serology and clinico-pathological data in cervical carcinoma patients: Prognostic value of anti-E6 and/or anti-E7 antibodies
3. Immune responses against human papillomavirus (HPV) type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia. II. Systemic but not local IgA responses correlate with clearance of HPV-16
4. Prevalence of human papillomavirus in cervical cancer: A worldwide perspective
5. Immunologic diagnosis and monitoring of cervical cancers using in vitro translated HPV proteins
6. Normal uterine cervix: Characterization of isolated lymphocyte phenotypes and immunoglobulin secretion
7. Detection of IgA antibodies against human papillomavirus in cervical secretions from patients with cervical intraepithelial neoplasia
8. Antibodies against papillomavirus antigens in cervical secretions from condyloma patients
9. Seric and local antibodies against a synthetic peptide of HPV16
10. The association of human papillomavirus type 16 E6 and E7 antibodies with stage of cervical cancer
11. Serological assays for the detection of HPV antibodies
12. Immunologic responses to human papillomavirus infection
13. Detection of cervical antibodies to human papillomavirus type 16 (HPV-16) capsid antigens in relation to detection of HPV-16 DNA and cervical lesions
14. Systemic and secretory humoral immunity in the normal human vaginal tract
15. Oncogenic association of specific human papillomavirus types with cervical neoplasia
16. Antibodies against early proteins of human papillomaviruses as diagnostic markers for invasive cervical cancer
17. Antibodies to HPV-16 E6 and E7 proteins as markers for HPV-16- associated invasive cervical cancer
18. Absence of antibody against human papillomavirus type 16 E6 and E7 in patients with cervical cancer is independent of sequence variations
19. HPV-16-related proteins as the serologic markers in cervical neoplasia
20. International histological classification of tumours No. 8
21. Immunoglobulin production in human mixed lymphocyte cultures: Implications for co-cultures of cells from patients and healthy donors
22. Absence of human papillomavirus DNA from esophageal carcinoma as determined by multiple broad spectrum polymerase chain reactions
23. Detection of cutaneous and genital HPV types in clinical samples by PCR using consensus primers
24. Increased IL-6 and IL-8 levels in cervicovaginal secretions of patients with cervical cancer
25. IgG antibodies against human papillomavirus type 16 E7 proteins in cervicovaginal washing fluid from patients with cervical neoplasia
26. Human papillomavirus DNA and anti-HPV secretory IgA antibodies in cytologically normal cervical specimens
27. Telomerase activity as a biomarker for (pre)neoplastic cervical disease in scrapings and frozen sections from patients with abnormal cervical smear
28. Anti-bodies against oncoproteins E6 and E7 of human papillomavirus types 16 and 18 in cervical-carcinoma patients from Russia
29. Papillomavirus infections - A major cause of human cancers